We recently characterized (Moebius, F. F., Burrows, G. G., Striessnig, J., and Glossmann H.(1993) Mol. Pharmacol. 43, 139-144) and purified (Moebius, F. F., Hanner, M., Knaus, H. G., Weber, F., Striessnig, J., and Glossmann, H.(1994) J. Biol. Chem. 269, 29314-29320) a binding protein for the phenylalkylamine Ca antagonist emopamil. The emopamil-binding protein (EBP) acts as a high affinity acceptor for several antiischemic drugs and thus represents a potential common molecular target for antiischemic drug action. Degenerate oligonucleotides were synthesized according to the N-terminal amino acid sequence of purified EBP and used to amplify a guinea pig cDNA with reverse transcriptase-polymerase chain reaction and to clone full-length cDNAs from guinea pig and human liver cDNA libraries. The cDNAs coded for 229 (guinea pig) and 230 (human) amino acid 27-kDa polypeptides without significant sequence homology with any known protein. However, EBP shared structural features with pro- and eukaryotic drug transport proteins. The amino acid identity between human and guinea pig EBP was 73%. Hydrophobicity plots predicted four transmembrane segments. The C terminus contained a lysine-rich consensus sequence for the retrieval of type I integral membrane proteins to the endoplasmic reticulum. The heterologous expression of human and guinea pig EBP in Saccharomyces cerevisiae demonstrated that the expression of EBP alone is sufficient to form high affinity drug- and cation-binding domains identical to the [H]-emopamil-binding site of guinea pig liver. Northern and Western blot analysis revealed high abundance of EBP in guinea pig epithelial tissues as liver, bowel, adrenal gland, testis, ovary, and uterus and low densities in brain, cerebellum, skeletal muscle, and heart. EBP is suggested to be the first structurally characterized member of a family of high affinity microsomal drug acceptor proteins carrying so called -binding sites.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				A. Gioti, J. M. Pradier, E. Fournier, P. Le Pecheur, C. Giraud, D. Debieu, J. Bach, P. Leroux, and C. Levis A Botrytis cinerea Emopamil Binding Domain Protein, Required for Full Virulence, Belongs to a Eukaryotic Superfamily Which Has Expanded in Euascomycetes Eukaryot. Cell, February 1, 2008; 7(2): 368 - 378. [Abstract] [Full Text] [PDF]

				B. Kedjouar, P. de Medina, M. Oulad-Abdelghani, B. Payre, S. Silvente-Poirot, G. Favre, J.-C. Faye, and M. Poirot Molecular Characterization of the Microsomal Tamoxifen Binding Site J. Biol. Chem., August 6, 2004; 279(32): 34048 - 34061. [Abstract] [Full Text] [PDF]

				K. Misawa, T. Horiba, N. Arimura, Y. Hirano, J. Inoue, N. Emoto, H. Shimano, M. Shimizu, and R. Sato Sterol Regulatory Element-binding Protein-2 Interacts with Hepatocyte Nuclear Factor-4 to Enhance Sterol Isomerase Gene Expression in Hepatocytes J. Biol. Chem., September 19, 2003; 278(38): 36176 - 36182. [Abstract] [Full Text] [PDF]

				H. Vidal, G. Mondesert, S. Galiegue, D. Carriere, P.-H. Dupuy, P. Carayon, T. Combes, E. Bribes, J. Simony-Lafontaine, A. Kramar, et al. Identification and Pharmacological Characterization of SRBP-2: A Novel SR31747A-binding Protein Cancer Res., August 15, 2003; 63(16): 4809 - 4818. [Abstract] [Full Text] [PDF]

				G. E. Herman Disorders of cholesterol biosynthesis: prototypic metabolic malformation syndromes Hum. Mol. Genet., April 2, 2003; 12(90001): R75 - 88. [Abstract] [Full Text] [PDF]

				M. Souter, J. Topping, M. Pullen, J. Friml, K. Palme, R. Hackett, D. Grierson, and K. Lindsey hydra Mutants of Arabidopsis Are Defective in Sterol Profiles and Auxin and Ethylene Signaling PLANT CELL, May 1, 2002; 14(5): 1017 - 1031. [Abstract] [Full Text] [PDF]

				F. F. Moebius, R. J. Reiter, K. Bermoser, H. Glossmann, S. Y. Cho, and Y.-K. Paik Pharmacological Analysis of Sterol Delta 8-Delta 7 Isomerase Proteins with [3H]Ifenprodil Mol. Pharmacol., September 1, 1998; 54(3): 591 - 598. [Abstract] [Full Text]

				B. U. Fitzky, M. Witsch-Baumgartner, M. Erdel, J. N. Lee, Y.-K. Paik, H. Glossmann, G. Utermann, and F. F. Moebius Mutations in the Delta 7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome PNAS, July 7, 1998; 95(14): 8181 - 8186. [Abstract] [Full Text] [PDF]

				R. Paul, S. Silve, N. De Nys, P.-H. Dupuy, C. L.-L. Bouteiller, J. Rosenfeld, P. Ferrara, G. Le Fur, P. Casellas, and G. Loison Both the Immunosuppressant SR31747 and the Antiestrogen Tamoxifen Bind to an Emopamil-Insensitive Site of Mammalian Delta 8-Delta 7 Sterol Isomerase J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1296 - 1302. [Abstract] [Full Text]

				F. F. Moebius, B. U. Fitzky, J. N. Lee, Y.-K. Paik, and H. Glossmann Molecular cloning and expression of the human Delta 7-sterol reductase PNAS, February 17, 1998; 95(4): 1899 - 1902. [Abstract] [Full Text] [PDF]

				T. Lenz and J. W. Kleineke Hormone-induced rise in cytosolic Ca2+ in axolotl hepatocytes: properties of the Ca2+ influx channel Am J Physiol Cell Physiol, November 1, 1997; 273(5): C1526 - C1532. [Abstract] [Full Text] [PDF]

				S. Silve, P. H. Dupuy, C. Labit-Lebouteiller, M. Kaghad, P. Chalon, A. Rahier, M. Taton, J. Lupker, D. Shire, and G. Loison Emopamil-binding Protein, a Mammalian Protein That Binds a Series of Structurally Diverse Neuroprotective Agents, Exhibits Delta 8-Delta 7 Sterol Isomerase Activity in Yeast J. Biol. Chem., September 13, 1996; 271(37): 22434 - 22440. [Abstract] [Full Text] [PDF]